Hemophagocytic Syndrome (HPS) or Hemophagocytic Lymphohistiocytosis is characterized by a dysregulation of the immune system with activation of macrophages and T lymphocytes, the product of an uncontrollable and excessive inflammatory response to different stimuli. The case of a patient with a history of Human Immunodeficiency Virus (HIV) under current treatment is presented, a clinical picture of 10 days of evolution characterized by fever, anorexia and asthenia, on physical examination skin-mucosa paleness, dehydration, generalized lymphadenopathy, hepatosplenomegaly. Paraclinical tests are performed suggesting reactivation of infection by Cytomegalovirus (CMV), in addition, during its in-hospital evolution, marked pancytopenia is evidenced, with elevated ferritin values, a bone marrow biopsy is performed, observing proliferation of Histiocytes, the patient meets the diagnostic criteria for HPS proposed by the Histiocyte Society in 2004, treatment was instituted, however it presented a torpid evolution and reached death. It is concluded that the diagnosis of HPS is complex; it is usually overlapped by the underlying diseases, as is the case of this HIV patient with reactivation of CMV infection; both viruses by themselves are related to HPS; therefore, knowledge of the clinical and laboratory criteria of this entity is necessary to make an early diagnosis and establish timely treatment, thus reducing mortality.
Published in | European Journal of Clinical and Biomedical Sciences (Volume 7, Issue 6) |
DOI | 10.11648/j.ejcbs.20210706.16 |
Page(s) | 126-131 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2021. Published by Science Publishing Group |
Hemophagocytic Syndrome, Hemophagocytic Lymphohistiocytosis, Cytomegalovirus, Human Immunodeficiency Virus
[1] | Scott RB., & Robb-Smith AH. (1939). Histiocytic Medullary Reticulocytosis. The Lancet, 234: 194-198. |
[2] | Chung C., Estripeaut D., Rodriguez H & Rios C. (2010). Hemophagocytic syndrome associated with acute infection by Cytomegalovirus. Presentation of Clinical Case. Pediatrics Panama, 39 (2): 33-38. |
[3] | Warley F., Bonella B., Odstrcil-Bobillo M., Otero V., Waisma G., Bendelman G., Giunta D., Peuchot V., & Ungaro C. (2017). Clinical characteristics and mortality of adult patients with hemaphagocytic syndrome, retrospective cohort study. Rev Med Chile, 145 (3): 344-350. |
[4] | Pereira L., Dabezies A., Cuturi B., Fernández A., & Pérez W. (2018). Hemophagocytic lymphohistiocytosis. About a case. Archives of Pediatrics of Uruguay, 89 (2): 122-128. |
[5] | Iscano N., & Fajardo F. (2018). Hemophagocytic syndrome. J. Med. Hondur., 86 (3 and 4): 134-137. |
[6] | Egües C., Calvo J., Cabrera L., Sola A., Furundarena J., Alcorta N., Valero J., López L., Cancio J., Maiz O., Uriarte E., & Belzunegui J. (2020). Clinical characteristics and prognostic factors in patients with Hemophagocytic syndrome. Int. J. Rare Dis Disorder, 3 (020). |
[7] | Dávila D, & Peña IR. (2019). Hemophagocytic syndrome. Case report and literature review. Journal of the Faculty of Medicine of the UNAM, 62 (2): 15-21. |
[8] | Rosemberg M., Echavarría G., Ludueña A., Estrada G., & Molina M. (2018). Hemophagocytosis Secondary to Dengue. Medicine, 78 (1): 37-40. |
[9] | Santos L., Martínez O., & Milian G. (2017). Hemophagocytic syndrome. Case report and disease review. Medical Certificate of the Center, 11 (4): 38-45. |
[10] | Li J., Wang Q., Zheng W., Ma J., Zhang W., Wang W., & Tian X. (2014). Hemophagocytic Linfohistiocytosis. Analysis clinical of 103 adult patients. Medicine, 93 (2): 100-105. |
[11] | Espinosa K., García P., Fossas D., & León E. (2013). Hemophagocytic syndrome. Current concepts. Medical Gazette of Mexico, 149: 431-7. |
[12] | Parikh S. Kapoor P., Letendre L., Kumar S., & Wolansky A. (2014). Prognostic factors and outcomes in adults with hemophagocytic lymphohistiocytosis. May Clin. Proc, 89 (4): 484-492. |
[13] | Guijarro S. (2018). Hemophagocytic syndrome in a patient with acquired immunodeficiency syndrome: a case study. Therapeia 10: 145-150. |
[14] | Dos Santos G., Uría R., Silvera L., Santos C., Oliver C., Frantchez V., Cichero M., Solari P., Grille S., Sosa L., & Silvariño R. (2017). Hemophagocytic syndrome: a rare complication in the patient with human immunodeficiency virus (HIV) infection. Uruguayan Journal of Internal Medicine, 2 (1): 25-31. |
[15] | Rivière S., Galicier L., Coppo P., Marzac C., Aumont C., Lambotte O., & Fardet L. (2014). Reactive Hemophagocytic Syndrome in Adults: A Multicenter Retrospective Analysis of 162 Patients. The American Journal of Medicine, 127 (11): 1118-1125. |
APA Style
Elizabeth Castro, María Cepeda, Diego Ospina. (2021). Hemophagocytic Syndrome Secondary to Cytomegalovirus Infection in a Patient with Human Immunodeficiency Virus. European Journal of Clinical and Biomedical Sciences, 7(6), 126-131. https://doi.org/10.11648/j.ejcbs.20210706.16
ACS Style
Elizabeth Castro; María Cepeda; Diego Ospina. Hemophagocytic Syndrome Secondary to Cytomegalovirus Infection in a Patient with Human Immunodeficiency Virus. Eur. J. Clin. Biomed. Sci. 2021, 7(6), 126-131. doi: 10.11648/j.ejcbs.20210706.16
AMA Style
Elizabeth Castro, María Cepeda, Diego Ospina. Hemophagocytic Syndrome Secondary to Cytomegalovirus Infection in a Patient with Human Immunodeficiency Virus. Eur J Clin Biomed Sci. 2021;7(6):126-131. doi: 10.11648/j.ejcbs.20210706.16
@article{10.11648/j.ejcbs.20210706.16, author = {Elizabeth Castro and María Cepeda and Diego Ospina}, title = {Hemophagocytic Syndrome Secondary to Cytomegalovirus Infection in a Patient with Human Immunodeficiency Virus}, journal = {European Journal of Clinical and Biomedical Sciences}, volume = {7}, number = {6}, pages = {126-131}, doi = {10.11648/j.ejcbs.20210706.16}, url = {https://doi.org/10.11648/j.ejcbs.20210706.16}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ejcbs.20210706.16}, abstract = {Hemophagocytic Syndrome (HPS) or Hemophagocytic Lymphohistiocytosis is characterized by a dysregulation of the immune system with activation of macrophages and T lymphocytes, the product of an uncontrollable and excessive inflammatory response to different stimuli. The case of a patient with a history of Human Immunodeficiency Virus (HIV) under current treatment is presented, a clinical picture of 10 days of evolution characterized by fever, anorexia and asthenia, on physical examination skin-mucosa paleness, dehydration, generalized lymphadenopathy, hepatosplenomegaly. Paraclinical tests are performed suggesting reactivation of infection by Cytomegalovirus (CMV), in addition, during its in-hospital evolution, marked pancytopenia is evidenced, with elevated ferritin values, a bone marrow biopsy is performed, observing proliferation of Histiocytes, the patient meets the diagnostic criteria for HPS proposed by the Histiocyte Society in 2004, treatment was instituted, however it presented a torpid evolution and reached death. It is concluded that the diagnosis of HPS is complex; it is usually overlapped by the underlying diseases, as is the case of this HIV patient with reactivation of CMV infection; both viruses by themselves are related to HPS; therefore, knowledge of the clinical and laboratory criteria of this entity is necessary to make an early diagnosis and establish timely treatment, thus reducing mortality.}, year = {2021} }
TY - JOUR T1 - Hemophagocytic Syndrome Secondary to Cytomegalovirus Infection in a Patient with Human Immunodeficiency Virus AU - Elizabeth Castro AU - María Cepeda AU - Diego Ospina Y1 - 2021/11/27 PY - 2021 N1 - https://doi.org/10.11648/j.ejcbs.20210706.16 DO - 10.11648/j.ejcbs.20210706.16 T2 - European Journal of Clinical and Biomedical Sciences JF - European Journal of Clinical and Biomedical Sciences JO - European Journal of Clinical and Biomedical Sciences SP - 126 EP - 131 PB - Science Publishing Group SN - 2575-5005 UR - https://doi.org/10.11648/j.ejcbs.20210706.16 AB - Hemophagocytic Syndrome (HPS) or Hemophagocytic Lymphohistiocytosis is characterized by a dysregulation of the immune system with activation of macrophages and T lymphocytes, the product of an uncontrollable and excessive inflammatory response to different stimuli. The case of a patient with a history of Human Immunodeficiency Virus (HIV) under current treatment is presented, a clinical picture of 10 days of evolution characterized by fever, anorexia and asthenia, on physical examination skin-mucosa paleness, dehydration, generalized lymphadenopathy, hepatosplenomegaly. Paraclinical tests are performed suggesting reactivation of infection by Cytomegalovirus (CMV), in addition, during its in-hospital evolution, marked pancytopenia is evidenced, with elevated ferritin values, a bone marrow biopsy is performed, observing proliferation of Histiocytes, the patient meets the diagnostic criteria for HPS proposed by the Histiocyte Society in 2004, treatment was instituted, however it presented a torpid evolution and reached death. It is concluded that the diagnosis of HPS is complex; it is usually overlapped by the underlying diseases, as is the case of this HIV patient with reactivation of CMV infection; both viruses by themselves are related to HPS; therefore, knowledge of the clinical and laboratory criteria of this entity is necessary to make an early diagnosis and establish timely treatment, thus reducing mortality. VL - 7 IS - 6 ER -